Tonix Pharmaceuticals CEO Seth Lederman returns to New to the Street

Click the Subscribe button for the latest in crypto, blockchain and business news from NEW TO THE STREET!

#crypto #cryptocurrency #blockquake #blockchain #blockchainnews #digitalcurrency #newtothestreet #janeking #exploringtheblock #foxbusinessnews #foxbusiness #financialnews #businessnews #ai #newsmaxtv #tonixpharmaceutical

Tonix Pharmaceuticals recently announces the results of a interim analysis of phase three study for the drug candidate TNX102SL in fibromyalgia. CEO Seth Lederman visits New to the Street to discuss it further.

To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/channel/UCceRKKS0QUfXlKUPBoxdTHQ

Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet
Follow New to the Street on Facebook: https://www.facebook.com/newtothestreet/
Follow New to the Street on Instagram: https://www.instagram.com/newtothestreettv/
Follow New to the Street on Rumble: https://rumble.com/user/newtothestreet
About New to the Street: https://newtothestreet.com/

Subscribe to our Mailing List: https://mailchi.mp/ccd21b3e3fab/join-our-mailing-list